SCREEN-CUPMenstrual Cup for Endometrial Cancer Detection in Lynch Syndrome
Menstrual cup use
Urogenital Diseases+24
+ Genital Diseases
+ Colonic Diseases
Screening Study
Summary
Study start date: November 20, 2025
Actual date on which the first participant was enrolled.This clinical trial explores a new way to collect and test samples from inside the uterus, specifically targeting women with Lynch Syndrome, a genetic condition that increases the risk of endometrial cancer. The research investigates whether using a menstrual cup to collect these samples can be a good alternative to the traditional method, which involves a more invasive endometrial biopsy. This study is vital because it could offer a less uncomfortable and more convenient method for women with Lynch Syndrome to undergo regular screenings, potentially catching cancer signs earlier and improving overall care. Participants in the study will use a menstrual cup to collect a sample of their menstrual fluid, which will then be analyzed and compared to a sample obtained through the usual biopsy method. The researchers will look at the quality of the samples and how well they can be used to grow organoids, which are small, lab-grown versions of human tissues. The study also assesses how satisfied the women and healthcare providers are with this new method, gathering their feedback through surveys. This information could help determine if the menstrual cup method is a feasible and preferred option for regular cancer screenings in the future.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.25 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Screening Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Female
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
Study Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location